Pharmacy World & Science

, Volume 32, Issue 5, pp 610–621 | Cite as

An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role

  • Kreshnik HotiEmail author
  • Bruce Sunderland
  • Jeffery Hughes
  • Richard Parsons
Research article


Objectives To evaluate the views of Australian pharmacists on expanded pharmacist prescribing roles and identify important drivers and barriers to its implementation. Setting Pharmacists in Australia. Method Data were collected using a self-administered questionnaire distributed nationally to a random sample of pharmacists either directly, or in the case of one state, via community pharmacies. One-way ANOVA and ϰ2 testing were used to identify significant associations. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis. Mainoutcomemeasures Perceptions of Australian pharmacists on expanded prescribing and the relationships between variables derived. Results A total of 2592 questionnaires were distributed and a response rate of 40.4% was achieved (n = 1049). Of the respondents 83.9% strongly agreed/agreed to an expanded prescribing role for pharmacists and 97.1% reported they would need further training. Of the respondents 896 agreed that pharmacists should engage in supplementary, independent prescribing or both. Of these 69.1% preferred only supplementary prescribing, 3.3% independent prescribing and 27.4% both models. Both models were found to be positive predictors of expanding pharmaceutical services through prescribing (P < 0.001) with supplementary prescribing showing a stronger association (β = 0.52 vs. β = 0.18). Pharmacists’ opinion based on their current perceptions of their clients was an important predictor in expanding pharmaceutical services through prescribing (P = 0.005). Inadequate training in patient assessment, diagnosis and monitoring were the strongest barriers to expanded pharmacist prescribing (P < 0.001). Conclusions The majority of Australian pharmacists supported an expanded pharmacist prescribing role. Support for supplementary was stronger than independent prescribing. Pharmacists acknowledged that they would need further training to perform such roles.


Attitudes Australia Independent prescribing Pharmacists Pharmacist prescribing Supplementary prescribing 



The authors wish to acknowledge the contribution of pharmacists that participated in this study and statistical support provided by Jennifer Lalor and Associate Professor Satvinder Dhaliwal of Curtin University of Technology.

Conflicts of interest


Financial support

This research was entirely funded by Curtin University of Technology, School of Pharmacy.


  1. 1.
    Department of Health; Pharmacist Independent Prescribing; London, UK; March 2007. Accessed 29 April 2009.
  2. 2.
    Department of Health; improving patients’ access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England; April 2006. Accessed 28 April 2009.
  3. 3.
    Zellmer W. Collaborative drug therapy management. Am J Health Syst Pharm. 1995;52:1732.PubMedGoogle Scholar
  4. 4.
    Pearson G. Evolution in the practice of pharmacy-not a revolution. CMAJ. 2007;176:1295–6.PubMedGoogle Scholar
  5. 5.
    Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65:2126–32.CrossRefPubMedGoogle Scholar
  6. 6.
    Hobson R, Sewell G. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci. 2006;28:76–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Van Foppe MJ, Schultz M, Tromp TF. Pharmaceutical care, European developments in concepts, implementation, teaching and research: a review. Pharm World Sci. 2004;26:303–11.CrossRefGoogle Scholar
  8. 8.
    Kidd M, Watts I, Mitchell C. Principles for supporting task substitution in Australian general practice. Med J Aust. 2006;185:20–2.PubMedGoogle Scholar
  9. 9.
    Crown J. Review of prescribing, supply and administration of medicines. Final report. London, Department of Health; 1999. . Accessed 26 March 2009.
  10. 10.
    Royal Pharmaceutical Society of Great Britain. Prescribing of controlled drugs by pharmacist and nurse independent prescribers, Law and Ethics Bulletin, London, UK. Accessed 30 October 2009.
  11. 11.
    The Australian Government Productivity Commission. Australia’s health workforce. Productivity Commission research report, 22 Dec 2005. Canberra: Productivity Commission; 2005. Accessed 25 May 2009.
  12. 12.
    Yong C. Task substitution: the view of the Australian Medical Association. Med J Aust. 2006;185:27–8.PubMedGoogle Scholar
  13. 13.
    The Australian Medical Association. Patient safety paramount in medication prescriptions; Media Releases. 2008. Accessed 30 May 2009.
  14. 14.
    Sewell J. Task transfer: The view of the Royal Australasian College of Physicians. Med J Aust. 2006;185:23–4.PubMedGoogle Scholar
  15. 15.
    Australian Bureau of Statistics (ABS). 2006 census of population and housing, Canberra; 2008. Accessed 12 Jan 2009.
  16. 16.
    Kay OC, Bajorek BV, Brien JA. Pharmacist prescribing activities—an electronic survey on the opinions of Australian pharmacists. J Pharm Pract Res. 2006;36(3):199–203.Google Scholar
  17. 17.
    Tonna AP, Stewart D, West D, McCaig D. Pharmacist prescribing in the UK; a literature review of current practice and research. J Clin Pharm Ther. 2007;32:545–56.CrossRefPubMedGoogle Scholar
  18. 18.
    George J, McCaig D, Bond CM, et al. Supplementary prescribing: early experiences of pharmacists in the UK. Ann Pharmacother. 2006;40(10):1843–50.CrossRefPubMedGoogle Scholar
  19. 19.
    Kay OC, Brien JE. Pharmacist prescribing: review of the literature. J Pharm Pract Res. 2004;34(4):300–4.Google Scholar
  20. 20.
    Eng HJ. The pharmacist as prescriber. J Clin Pharm Ther. 1987;12:237–42.CrossRefPubMedGoogle Scholar
  21. 21.
    Segal R, Grines LL. Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry. Drug Intel Clin Pharm. 1988;22:241–6.Google Scholar
  22. 22.
    Bellingham C. Space, time and team working: issues for pharmacists who wish to prescribe. Pharm J. 2002;268:562–4.Google Scholar
  23. 23.
    Stimmel GL. Political and legal aspects of pharmacist prescribing. Am J Hosp Pharm. 1983;40:1343–4.PubMedGoogle Scholar
  24. 24.
    Del Mar C, Dwyer N. A radical new treatment for the sick health workforce. Med J Aust. 2006;185:32–4.PubMedGoogle Scholar
  25. 25.
    Joyce C, McNeill J. Fewer medical graduates are choosing general practice: a comparison of four cohorts, 1980–1995. Med J Aust. 2006;185:102–4.PubMedGoogle Scholar
  26. 26.
    Joyce C, McNeil A, Stoelwinder J. More doctors, but not enough: Australian medical workforce supply 2001–2012. Med J Aust. 2006;184:441–6.PubMedGoogle Scholar
  27. 27.
    Bessell T, Emmerton L, Marriot J, Nissen L. Improving Australians’ access to prescription medicines: proposed practice models. Pharmacy Canberra: Guild of Australia; June 2005. Accessed 22 March 2009.
  28. 28.
    Hanes CA, Bajorek BV. Pharmacist Prescribing: Views of Australian Hospital Pharmacists. J Pharm Pract Res. 2005;35(3):178–80.Google Scholar
  29. 29.
    Emmerton L, Marriot J, Bessell T, et al. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Kreshnik Hoti
    • 1
    Email author
  • Bruce Sunderland
    • 1
  • Jeffery Hughes
    • 1
  • Richard Parsons
    • 1
  1. 1.Curtin Health and Innovation Research Institute and School of PharmacyCurtin University of TechnologyPerthAustralia

Personalised recommendations